相关实验视频

Updated: Aug 9, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

绕过B细胞的反应,允许减少腺相关病毒载体的减少

Hildegund C J Ertl¹

¹Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, Pennsylvania, USA.

Human gene therapy

|October 20, 2023

概括

基因相关病毒 (AAV) 基因疗法面临免疫挑战,限制安全剂量. 开发用于管理AAV抗体的方法对于允许重复,更安全的治疗和重新给药患者至关重要.

科学领域:

基因治疗基因治疗
免疫学免疫学免疫学
病毒学病毒学

背景情况:

腺关联病毒 (AAV) 介导的基因疗法显示出有希望的结果,但由于免疫反应而面临重大障碍.
高剂量的AAV载体,通常需要治疗疗效,导致严重的不良事件 (SAE),包括死亡.
目前的免疫抑制药物在预防AAV相关的SAE方面不足.

研究的目的:

为了解决AAV基因治疗中免疫系统所造成的局限性.
探索使AAV载体在更安全,中等剂量中重复使用的策略.
为了促进AAV基因转移在患有先前存在的中和抗体的患者.

主要方法:

该研究讨论了新型免疫抑制疗法的必要性.
专注于阻止B细胞对AAV载体的反应的策略.
考虑治疗以消除先前存在的AAV中和抗体.

主要成果:

目前的免疫抑制并没有阻止与高剂量AAV载体相关的SAE.
AAV 载体引起中和抗体,阻碍了交叉反应载体的重复注射.
开发策略来管理AAV抗体是必不可少的.

结论:

从有毒的高剂量单次AAV注射转向重复的中剂量治疗是可取的.
预防或阻断抗体反应是减少剂量和改善基因治疗结果的关键.
有效的AAV基因转移需要克服先前存在的免疫力和管理抗AAV抗体.

关键词:

在 AAV AAV AAV 中.B 细胞 B 细胞 B 细胞基因转移是转移基因的过程.免疫抑制是一种免疫抑制.中和抗体中和抗体.

更多相关视频

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

相关概念视频

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...